THE EFFECT OF DOSE ON THE BIOAVAILABILITY OF ORAL ETOPOSIDE

被引：1

作者：

HARVEY, VJ

SLEVIN, ML

JOEL, SP

JOHNSTON, A

WRIGLEY, PFM

机构：

[1] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND

[2] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1M 6BQ,ENGLAND

[3] HACKNEY HOSP,LONDON,ENGLAND

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 16卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：178 / 181

页数：4

共 29 条

[1]

ARNOLD AM, 1979, CANCER CHEMOTH PHARM, V3, P71

[2]

ARNOLD AM, 1981, LANCET, V2, P912

[3]

BEVERIDGE T, 1976, BIOAVAILABILITY STUD

[4]

BRUNNER KW, 1796, CANCER TREAT REP, V60, P1377

[5] CURRENT DEVELOPMENT OF PODOPHYLLOTOXINS [J].

CANETTA, R ;

HILGARD, P ;

FLORENTINE, S ;

BEDOGNI, P ;

LENAZ, L .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :93-98

[6]

CAVALLI F, 1982, CANCER CHEMOTH PHARM, V7, P81

[7]

DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141

[8]

EDMUNDSON J, 1983, BRIT J CANCER, V48, P114

[9]

HANDE KR, 1982, P AM ASSOC CANC RES, V23, P131

[10] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ETOPOSIDE IN PLASMA AND URINE [J].

HARVEY, VJ ;

JOEL, SP ;

JOHNSTON, A ;

SLEVIN, ML .

JOURNAL OF CHROMATOGRAPHY, 1985, 339 (02) :419-423

← 1 2 3 →